ArticleCureus2025
First-Trimester Complete Blood Count as a Predictor of Gestational Diabetes Mellitus: A Multi-center Primary Health Care Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gestational diabetes mellitus (GDM) is a common pregnancy complication linked to significant maternal and neonatal risks, such as fetal risk of large for gestational age (LGA) and polyhydramnios. This study aimed to evaluate the predictive value of first-trimester complete blood count (CBC) parameters - particularly neutrophil count - for the development of GDM among women attending National Guard primary care centers in Jeddah, Saudi Arabia. Methods A retrospective cohort study was conducted using records from January 2023 to January 2024. Pregnant women aged 18-45 years who completed first-trimester laboratory testing and underwent GDM screening at 24-28 weeks were included. Women with pre-existing diabetes, chronic illnesses, or signs of ongoing infections were excluded. Clinical, laboratory, and pregnancy outcome data were analyzed using IBM SPSS Statistics for Windows, Version 29 (released 2022; IBM Corp., Armonk, NY, USA), employing t-tests, chi-square tests, and binary logistic regression to identify significant predictors. Results Among 399 women, 25.6% developed GDM. Significant predictors included older maternal age, higher body mass index (BMI), excessive gestational weight gain, and a history of previous GDM (p < 0.001). Laboratory findings showed elevated fasting glucose and red blood cell (RBC) counts in the GDM group, while neutrophil count and neutrophil-to-lymphocyte ratio (NLR) were not statistically significant predictors. Logistic regression confirmed that the one-hour oral glucose tolerance test (OGTT) value, total weight gain, and previous GDM history were independent predictors, with OGTT showing the strongest association (OR = 3.878, p < 0.001). Conclusion Traditional risk factors, including maternal age, BMI, weight gain, and GDM history, remain crucial for GDM prediction. First-trimester neutrophil counts did not show predictive value, suggesting limited utility as early inflammatory markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.